AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Update on Oral Minoxidil

Description

The presentation discusses the effects and considerations of using oral minoxidil in treating various hair disorders, highlighting its anti-inflammatory, anti-androgenic, and anti-fibrotic properties. The speaker emphasizes the balance between efficacy and potential side effects, noting that higher doses increase the likelihood of adverse effects. Individualized dosing is crucial, as some patients tolerate higher doses better than others. The use of sublingual minoxidil is gaining popularity due to its safety and efficacy, bypassing hepatic metabolism. The speaker mentions that while oral minoxidil can lead to mild hypotension in normotensive patients, it can cause tachycardia, which should be monitored, especially in those with cardiovascular issues. Edema is another possible side effect, and dosage adjustments can mitigate this. The presentation underlines the importance of screening for cardiovascular histories before prescribing. Overall, oral minoxidil can be an effective standalone or adjunct treatment for hair loss, but practitioners need to consider patient-specific factors and potential side effects.

View more

Conclusions

  • Minoxidil shows various effects that contribute to its efficacy in treating hair disorders, including anti-inflammatory, anti-androgenic, and anti-fibrotic properties.
  • The efficacy and side effects of oral minoxidil are dose-dependent, with higher doses correlating with better results and increased side effects.
  • Patients with a history of cardiovascular disorders, excessive hair due to hirsutism, or previous epilation treatments should be treated cautiously or excluded from minoxidil therapy.
  • Oral minoxidil can be safely combined with topical treatments, enhancing overall efficacy.
  • Sublingual minoxidil may provide better bioavailability and reduce potential hepatic side effects compared to traditional oral forms.
  • The majority of side effects reported are generally mild, but they can be severe in patients with underlying cardiac conditions.
  • Patients under treatment for hypertension can often start low-dose oral minoxidil without needing a cardiology referral.
  • Less common side effects such as tachycardia and edema should be monitored, and adjustments to dosage may be necessary.
  • Oral minoxidil is well tolerated in pediatric populations and can be effective for various hair loss conditions.
  • Clinicians should routinely check for cardiovascular risk factors when prescribing oral minoxidil.
  • Gupta AK, Hall DC, Talukder M, Bamimore MA. There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses. Skin Appendage Disord. 2022 Sep;8(5):355-361.
  • Bokhari L, Jones LN, Sinclair RD. Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial. J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e62-e66.
  • Sanabria BD et al. Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia. J Am Acad Dermatol. 2022 May 18:S0190-9622(22)00821-0.
  • Jimenez-Cauhe J, Pirmez R, Müller-Ramos P et al. Safety of Low-Dose Oral Minoxidil in Patients With Hypertension and Arrhythmia: A Multicenter Study of 264 Patients. Actas Dermosifiliogr. 2024 Jan;115(1):28-35.
  • Mir-Bonafé JF, Mir-Bonafé M, Rozas-Muñoz E, Mir-Bonafé JM. Morning Periorbital Edema Related to Low-Dose Oral Minoxidil. Actas Dermosifiliogr. 2022 Apr 29:S0001-7310(22)00298-8.
  • Moussa A, Kazmi A, Bokhari L, Sinclair RD. Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients. J Am Acad Dermatol. 2022 Aug;87(2):488-490.
  • Sánchez-Díaz M, López-Delgado D, Montero-Vílchez T, Salvador-Rodríguez L, Molina-Leyva A, Tercedor-Sánchez J, Arias-Santiago S. Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects. J Clin Med. 2021 Sep 20;10(18):4257. doi: 10.3390/jcm10184257.